(MENAFN- PR Newswire) PANAMA CITY, April 18, 2024 /PRNewswire/ -- Banco Latinoamericano de Comercio Exterior, S.A. ("Bladex" or the "Bank"), announced today its Board of Directors' approval of a quarterly cash dividend of US$0.50 per share corresponding to the first quarter of 2024.The cash dividend is payable May 15, 2024 to the Bank's stockholders as of April 29, 2024 record date.
As of March 31, 2024, Bladex had 36,727,297.73 shares outstanding of all classes.
Bladex, a multinational bank originally established by the central banks of Latin-American and Caribbean countries, began operations in 1979 to promote foreign trade and economic integration in the Region.
The Bank, headquartered in Panama, also has offices in Argentina, Brazil, Colombia, Mexico, the United States of America, and a Representative License in Peru, supporting the regional expansion and servicing of its customer base, which includes financial institutions and corporations.
Bladex is listed on the NYSE in the United States of America (NYSE: BLX ), since 1992, and its shareholders include: central banks and state-owned banks and entities representing 23 Latin American countries, commercial banks and financial institutions, and institutional and retail investors through its public listing.
For further information on Bladex, please access its website at or contact:
| Carlos Daniel Raad – Chief Investor Relations Officer E-mail address: [email protected] / [email protected] . Tel.: (+507) 366-4925 ext. 7925 Head Office Address: Torre V, Business Park, Ave. La Rotonda, Urb. Costa del Este, Panama, Republic of Panama |
SOURCE Banco Latinoamericano de Comercio Exterior, S.A. (Bladex)
MENAFN18042024003732001241ID1108113488
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.